Understanding diversity of human innate immunity receptors: Analysis of surface features of leucine-rich repeat domains in NLRs and TLRs

BMC Immunology

Volumn 10, Issue , 2009, Pages 48-

  Istomin, Andrei Y ^a   Godzik, Adam ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; LEUCINE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; TOLL LIKE RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTAL STRUCTURE; GLYCOSYLATION; HUMAN; HYDROPHOBICITY; INNATE IMMUNITY; MOLECULAR PHYLOGENY; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SEQUENCE HOMOLOGY; THREE DIMENSIONAL IMAGING;

CLUSTER ANALYSIS; GLYCOSYLATION; HUMANS; HYDROPHOBICITY; IMMUNITY, INNATE; NOD SIGNALING ADAPTOR PROTEINS; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; SURFACE PROPERTIES; TOLL-LIKE RECEPTORS;

EID: 70349880423     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-10-48     Document Type: Article

References (53)

1. Ting JP-Y, Lovering RC, Alnemri ES, Bertin J, Boss JM, Davis BK, Flavell RA, Girardin SE, Godzik A, Harton JA. The NLR gene family: a standard nomenclature. Immunity 2008, 28:285-287. 10.1016/j.immuni.2008.02.005, 2630772, 18341998.
2. Becker CE, O'Neill LAJ. Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin Immunopathol 2007, 29:239-248. 10.1007/s00281-007-0081-4, 17805544.
3. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Diff 2007, 14:10-22.
4. Ting JP, Willingham SB, Bergstralh DT. NLRs at the intersection of cell death and immunity. Nat Rev Immunol 2008, 8:372-379. 10.1038/nri2296, 18362948.
5. Holland LZ, Albalat R, Azumi K, Benito-Gutierrez E, Blow MJ, Bronner-Fraser M, Brunet F, Butts T, Candiani S, Dishaw LJ. The amphioxus genome illuminates vertebrate origins and cephalochordate biology. Genome Research 2008, 18:1100-1111. 10.1101/gr.073676.107, 2493399, 18562680.
6. Zhang Q, Zmasek CM, Dishaw LJ, Mueller MG, Ye Y, Litman GW, Godzik A. Novel genes dramatically alter regulatory network topology in amphioxus. Genome Biol 2008, 9:121-129.
7. Litman GW, Dishaw LJ, Cannon JP, Haire RN, Rast JP. Alternative mechanisms of immune receptor diversity. Curr Opin Immunol 2007, 19:526-534. 10.1016/j.coi.2007.07.001, 2065753, 17703932.
8. Gewirtz AT. TLRs in the Gut. III. Immune responses to flagellin in Crohn's disease: good, bad, or irrelevant?. Am J Physiol Gastrointest Liver Physiol 2007, 292:G706-G710. 10.1152/ajpgi.00347.2006, 17038626.
9. Koller B, Kappler M, Latzin P, Gaggar A, Schreiner M, Takyar S, Kormann M, Kabesch M, Roos D, Griese M, Hartl D. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol 2008, 181:2753-2763.
10. Szebeni B, Veres G, Dezsõfi A, Rusai K, Vannay T, Mraz M, Majorova E, Arató A. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clinical Exp Immunol 2008, 151:34-41.
11. Ozen S, Berdeli A, Turel B, Kutlay S, Yalcinkaya F, Arici M, Besbas N, Bakkaloglu A, Yilmaz E. Arg753Gln TLR-2 polymorphism in familial Mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease. J Rheumatol 2006, 33:2498-2500.
12. Varoga D, Paulsen F, Mentlein R, Fay J, Kurz B, Schütz R, Wruck C, Goldring MB, Pufe T. TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease. J Pathol 2006, 210:315-324. 10.1002/path.2059, 16981238.
13. Jin MS, Lee JO. Structures of the toll-like receptor family and its ligand complexes. Immunity 2008, 29:182-191. 10.1016/j.immuni.2008.07.007, 18701082.
14. Faustin B, Lartigue L, Bruey J-M, Luciano F, Sergienko E, Bailly-Maitre B, Volkmann N, Hanein D, Rouiller I, Reed JC. Reconstituted NALP1 Inflammasome Reveals Two-Step Mechanism of Caspase-1 Activation. Mol Cell 2007, 25:713-724. 10.1016/j.molcel.2007.01.032, 17349957.
15. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW. Three-dimensional structure of the apoptosome-Implications for assembly, procaspase-9 binding, and activation. Mol Cell 2002, 9:423-432. 10.1016/S1097-2765(02)00442-2, 11864614.
16. Lupas AN, Martin J. AAA proteins. Curr Opin Struct Biol 2002, 12:746-753. 10.1016/S0959-440X(02)00388-3, 12504679.
17. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jéhanno M, Viala J, Tedin K, Taha M-K, Labigne A, Zaehringer U. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003, 300:1584-1587. 10.1126/science.1084677, 12791997.
18. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003, 278:8869-8872. 10.1074/jbc.C200651200, 12527755.
19. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J Biol Chem 2003, 278:5509-5512. 10.1074/jbc.C200673200, 12514169.
20. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004, 20:243-244. 10.1016/S1074-7613(04)00046-9, 15030767.
21. Koike R, Kubota T, Hara Y, Ito S, Suzuki K, Yanagisawa K, Uchibori K, Miyasaka N. A case of Muckle-Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin). Mod Rheumatol 2007, 17:496-499. 10.1007/s10165-007-0616-5, 18084703.
22. Eckmann L, Karin M. NOD2 and Crohn's disease: loss or gain of function?. Immunity 2005, 22:661-667. 10.1016/j.immuni.2005.06.004, 15963781.
23. Franchi L, Amer A, Body-Malapel M, Kanneganti T-D, Özören N, Jagirdar R, Inohara N, Vandenabeele P, Bertin J, Coyle A. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1 in salmonella-infected macrophages. Nat Immunol 2006, 7:576-582. 10.1038/ni1346, 16648852.
24. Miao E, Andersen-Nissen E, Warren S, Aderem A. TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Seminars in Immunopathol 2007, 29:275-288.
25. Sutterwala FS, Flavell RA. NLRC4/IPAF: a CARD carrying member of the NLR family. Clinical Immunol 2009, 130:2-6.
26. Sisk TJ, Nickerson K, Kwok RPS, Chang C-H. Phosphorylation of class II transactivator regulates its interaction ability and transactivation function. Int Immunol 2003, 15:1195-1205. 10.1093/intimm/dxg116, 13679389.
27. Al-Kandari W, Jambunathan S, Navalgund V, Koneni R, Freer M, Parimi N, Mudhasani R, Fontes JD. ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcription. Mol Immunol 2007, 44:311-321. 10.1016/j.molimm.2006.02.029, 1624858, 16600381.
28. Kobe B, Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 1993, 366:751-756. 10.1038/366751a0, 8264799.
29. Kobe B, Deisenhofer J. Crystallization and preliminary x-ray analysis of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. J Mol Biol 1993, 231:137-140. 10.1006/jmbi.1993.1263, 8496959.
30. Enkhbayar P, Kamiya M, Osaki M, Matsumoto T, Matsushima N. Structural Principles of Leucine-Rich Repeat (LRR) Proteins. Proteins: Struc, Func, and Bioinf 2003, 54:394-403.
31. Kajava AV, Kobe B. Assessment of the ability to model proteins with leucine-rich repeats in light of the latest structural information. Prot Sci 2002, 11:1082-1090.
32. Kajava AV, Vassart G, Wodak SJ. Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats. Structure 1995, 3:867-877. 10.1016/S0969-2126(01)00222-2, 8535781.
33. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001, 11:725-732. 10.1016/S0959-440X(01)00266-4, 11751054.
34. Dangl JL, Jones JDG. Plant pathogens and integrated defence responses to infection. Nature 2001, 411:826-833. 10.1038/35081161, 11459065.
35. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R. Clustal W and Clustal X version 2.0. Bioinf 2007, 23:2947-2948.
36. Hubbard TJP, Aken BL, Beal K, Ballester B, Caccamo M, Chen Y, Clarke L, Coates G, Cunningham F, Cutts T. Ensembl 2007. Nucleic Acids Research 2007, 35:D610-D617. 10.1093/nar/gkl996, 1761443, 17148474.
37. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis 1997, 18:2714-2723. 10.1002/elps.1150181505, 9504803.
38. Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 2003, 31:3381-3385. 10.1093/nar/gkg520, 168927, 12824332.
39. Xu F, Ye Y, Godzik A. Exon/3D structure correlation defines binding specificity in a family of receptor domains. 2009,
40. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982, 157:105-132. 10.1016/0022-2836(82)90515-0, 7108955.
41. Saldanha AJ. Java Treeview-extensible visualization of microarray data. Bioinf 2004, 20:3246-3248.
42. Sun J, Duffy KE, Ranjith-Kumar CT, Xiong J, Lamb RJ, Santos J, Masarapu H, Cunningham M, Holzenburg A, Sarisky RT. Structural and functional analyses of the human Toll-like receptor 3: role of glycosylation. J Biol Chem 2006, 281:11144-11151. 10.1074/jbc.M510442200, 16533755.
43. Weber ANR, Morse MA, Gay NJ. Four N-linked glycosylation sites in human Toll-like receptor 2 cooperate to direct efficient biosynthesis and secretion. J Biol Chem 2004, 279:34589-34594. 10.1074/jbc.M403830200, 15173186.
44. Andersen-Nissen E, Smith KD, Bonneau R, Strong RK, Aderem A. A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J Exp Med 2007, 204:393-403. 10.1084/jem.20061400, 2118731, 17283206.
45. Ponsuksili S, Brunner RM, Goldammer T, Kühn C, Walz C, Chomdej S, Tesfaye D, Schellander K, Wimmers K, Schwerin M. Bovine NALP5, NALP8, and NALP9 Genes: Assignment to a QTL Region and the Expression in Adult Tissues, Oocytes, and Preimplantation Embryos. Biol Reproduct 2006, 74:577-584.
46. Westerveld GH, Korver CM, van Pelt AMM, Leschot NJ, Veen F, Repping S, Lombardi MP. Mutations in the testis-specific NALP14 gene in men suffering from spermatogenic failure. Hum Reproduc 2006, 21:3178-3184.
47. Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES. Autoimmune Polyendocrine Syndrome Type 1 and NALP5, a Parathyroid Autoantigen. N Engl J Med 2008, 358:1018-1028. 10.1056/NEJMoa0706487, 18322283.
48. Lo CF, Ning X, Gonzales C, Ozenberger BA. Induced expression of death domain genes NALP1 and NALP5 following neuronal injury. Biochem Biophys Res Comm 2008, 366:664-669. 10.1016/j.bbrc.2007.11.174, 18068672.
49. Grenier JM, Wang L, Manji GA, Huang WJ, Al-Garawi A, Kelly R, Carlson A, Merriam S, Lora JM, Briskin M. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS Lett 2002, 530:73-78. 10.1016/S0014-5793(02)03416-6, 12387869.
50. Wang L, Manji GA, Grenier JM, Al-Garawi A, Merriam S, Lora JM, Geddes BJ, Briskin M, DiStefano PS, Bertin J. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NFkappa B and caspase-1-dependent cytokine processing. J Biol Chem 2002, 277:29874-29880. 10.1074/jbc.M203915200, 12019269.
51. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, Bagga R, Kircheisen R, Ao A, Ratti B. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nature Genetics 2006, 38:300-302. 10.1038/ng1740, 16462743.
52. Lich JD, Williams KL, Moore CB, Arthur JC, Davis BK, Taxman DJ, Ting JP. Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J Immunol 2007, 178:1256-1260.
53. Lamkanfi M, Amer A, Kanneganti TD, Munoz-Planillo R, Chen G, Vandenabeele P, Fortier A, Gros P, Nunez G. The Nod-like receptor family member Naip5/Birc1e restricts Legionella pneumophila growth independently of caspase-1 activation. J Immunol 2007, 178:8022-8027.